Cargando…
Successful intrauterine treatment of a patient with cobalamin C defect
Cobalamin C (cblC) defect is an inherited autosomal recessive disorder that affects cobalamin metabolism. Patients are treated with hydroxycobalamin to ameliorate the clinical features of early-onset disease and prevent clinical symptoms in late-onset disease. Here we describe a patient in whom pren...
Autores principales: | Trefz, Friedrich K., Scheible, Dagmar, Frauendienst-Egger, Georg, Huemer, Martina, Suomala, Terttu, Fowler, Brian, Haas, Dorothea, Baumgartner, Matthias R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789385/ https://www.ncbi.nlm.nih.gov/pubmed/27014578 http://dx.doi.org/10.1016/j.ymgmr.2016.01.005 |
Ejemplares similares
-
Phenylketonuria (PKU) Urinary Metabolomic Phenotype Is Defined by Genotype and Metabolite Imbalance: Results in 51 Early Treated Patients Using Ex Vivo (1)H-NMR Analysis
por: Cannet, Claire, et al.
Publicado: (2023) -
Delayed Diagnosis of Cobalamin E Defect in an Adolescent Patient
por: Yekedüz, Merve Koç, et al.
Publicado: (2020) -
Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy
por: Huemer, Martina, et al.
Publicado: (2014) -
Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency
por: Obeid, Rima, et al.
Publicado: (2015) -
Review of cobalamin status and disorders of cobalamin metabolism in dogs
por: Kather, Stefanie, et al.
Publicado: (2019)